4826
S. R. Mandadapu et al. / Bioorg. Med. Chem. Lett. 22 (2012) 4820–4826
5. Khan, M. A.; Bass, D. M. Curr. Opin. Gastroenterol. 2010, 26, 26.
6. (a) Glass, R. I.; Parashar, U. D.; Estes, M. K. N. Eng. J. Med. 2009, 361, 1776; (b)
Tan, M.; Jiang, X. Curr. Opin. Invest. Drugs 2008, 9, 146.
27. Kuo, C.-J.; Shie, J.-J.; Fang, J.-M.; Yen, G.-R.; Hsu, J. T.-A.; Liu, H.-G.; Tseng, S.-N.;
Chang, S.-C.; Lee, C.-Y.; Shih, S.-R.; Liang, P.-H. Bioorg. Med. Chem. 2008, 16,
7388.
7. Blakeney, S. J.; Cahill, A.; Reilly, P. A. Virology 2003, 308, 216.
8. Tiew, K.-C.; He, G.; Aravapalli, S.; Mandadapu, S. R.; Gunnam, M. R.; Alliston, K.
R.; Lushington, G. H.; Kim, Y.; Chang, K.-O.; Groutas, W. C. Bioorg. Med. Chem.
Lett. 2011, 21, 5315.
9. Zeitler, C. E.; Estes, M. K.; Prasad Venkatarman, B. V. J. Virol. 2006, 80, 5050.
10. Nakamura, K.; Someya, Y.; Kumasaka, T.; Ueno, G.; Yamamoto, M.; Sato, T.;
Takeda, N.; Miyamura, T.; Tanaka, N. J. Virol. 2005, 79, 13685.
11. Hussey, R. J.; Coates, L.; Gill, R. S.; Erskine, P. T.; Coker, S.-F.; Mitchell, E.;
Cooper, J. B.; Wood, S.; Broadbridge, R.; Clarke, I. N.; Lambden, P. R.; Shoolingin-
Jordan, P. M. Biochemistry 2011, 50, 240.
28. Mou, K.; Xu, B.; Ma, C.; Yang, X.; Zou, X.; Lu, Y.; Xu, P. Bioorg. Med. Chem. Lett.
2008, 18, 2198.
29. Bogen, S. L.; Arasappan, A.; Velazquez, F.; Blackman, M.; Huelgas, R.; Pan, W.;
Siegel, E.; Nair, L. G.; Venkatraman, S.; Guo, Z.; Dolle, R.; Shi, N.-Y.; Njoroge, F.
G. Bioorg. Med. Chem. 1854, 2010, 18.
30. Ezzili, C.; Mileni, M.; McGlinchey, N.; Long, J. Z.; Kinsey, S. G.; Hochstatter, D.
G.; Stevens, R. C.; Lichtman, A. H.; Cravatt, B. F.; Bilsky, E. J.; Boger, D. L. J. Med.
Chem. 2011, 54, 2805.
31. Edwards, P. D.; Wolanin, D. J.; Andisik, D. W.; David, M. W. J. Med. Chem. 1995,
38, 76.
12. Kim, Y.; Lovell, S.; Tiew, K-C.; Mandadapu, S. R.; Alliston, K. R.; Battaille, K. P.;
Groutas, W. C.; Chang, K.-O., submitted for publication.
32. Chang, K. O.; Sosnovtsev, S. V.; Belliot, G.; King, A. D.; Green, K. Y. Virology 2006,
2, 463.
13. Dou, D.; Tiew, K.-C.; He, G.; Mandadapu, S. R.; Aravapalli, S.; Alliston, K. R.; Kim,
Y.; Chang, K.-O.; Groutas, W. C. Bioorg. Med. Chem. 2011, 19, 5975.
14. Dou, D.; Mandadapu, S. R.; Alliston, K. R.; Kim, Y.; Chang, K.-O.; Groutas, W. C.
Bioorg. Med. Chem. 2011, 19, 5749.
15. Dou, D.; Mandadapu, S. R.; Alliston, K. R.; Kim, Y.; Chang, K.-O.; Groutas, W. C.
Eur. J. Med. Chem. 2012, 47, 59.
16. Dou, D.; He, G.; Mandadapu, S. R.; Aravapalli, S.; Kim, Y.; Chang, K.-O.; Groutas,
W. C. Bioorg. Med. Chem. Lett. 2012, 22, 377.
17. Dou, D.; Tiew, K.-C.; Mandadapu, S. R.; Gunnam, M. R.; Alliston, K. R.; Kim, Y.;
Chang, K.-O.; Groutas, W. C. Bioorg. Med. Chem. 2012, 20, 2111.
18. Lipinski, C. A. J. Pharmacol. Toxicol. Methods 2000, 44, 235.
19. Veber, D. F. J. Med. Chem. 2002, 45, 2615.
20. Ritchie, T. J.; Ertl, P.; Lewis, R. Drug Discovery Today 2011, 16, 65.
21. Gleeson, M. P. J. Med. Chem. 2008, 51, 817.
22. Johnson, T. W.; Dress, K. R.; Edwards, M. Bioorg. Med. Chem. Lett. 2009, 19, 5560.
23. Perola, E. J. Med. Chem. 2010, 53, 2986.
24. Edwards, M. P.; Price, D. A. Ann. Rep. Med. Chem. 2010, 45, 381.
25. All compounds were characterized by 1H NMR and HRMS and had a >95%
purity.
26. (a) Webber, S. E.; Okano, K.; Little, T. L.; Reich, S. H.; Xin, Y.; Fuhrman, S. A.;
Matthews, D. A.; Love, R. A.; Hendrickson, T. F.; Patick, A. K.; Meador, J. W.;
Ferre, R. A.; Brown, E. L.; Ford, C. E.; Binford, S. L.; Worland, S. T. J. Med. Chem.
1998, 41, 2786; (b) Dragovich, P. S.; Prins, T. J.; Zhou, R.; Webber, S. E.;
Marakovits, J. T.; Fuhrman, S. A.; Patick, A. K.; Matthews, D. A.; Lee, C. A.; Ford,
C. E.; Burke, B. J.; Rejto, P. A.; Hendrickson, T. F.; Tuntland, T.; Brown, E. L.;
Meador, J. W.; Ferre, R. A.; Harr, J. E.; Kosa, M. B.; Worland, S. T. J. Med. Chem.
1999, 42, 1213.
33. Chang, K. O.; George, D. W. J. Virol. 2007, 22, 12111.
34. Chang, K. O. J. Virol. 2009, 83, 8587.
35. Kim, Y.; Thapa, M.; Hua, D. H.; Chang, K.-O. Antiviral Res. 2011, 89, 165.
36. Imperiali, B.; Abeles, R. H. Biochemistry 1987, 26, 4474.
37. Dai, Y.; Hedstrom, L.; Abeles, R. H. Biochemistry 2000, 39, 6498.
38. The receptor structure was prepared by extracting the co-crystallized
covalently-bound peptidyl ligand in 2IP711 and all resolved water. Protons
were added to the remaining structure using SYBYL39 and the covalently-
bound ligands (compounds 6a and 6h) were assembled sequentially as
follows: beginning with the bare sulfur on Cys 139 left from deletion of the
co-crystallized ligand, SYBYL was used to add the nearest ligand heavy atom,
protons were added to the resulting complex, and then the ligand position was
optimized using molecular mechanics (Tripos Molecular Force Field40),
Gasteiger–Marsili electrostatics41 and default convergence criteria. All
protein atomic coordinates were held fixed except for those of Cys139. From
the resulting optimized structure, terminal protons on the ligand fragment
were replaced with those heavy atoms corresponding to next-nearest
neighbors to the Cys139 sulfur attachment point, protons were added to the
resulting complex, and the structure re-optimized. Next–next nearest
neighbors were then added in a similar manner and continued incrementally
until the ligand was fully constituted.
39. SYBYL 8.1, Tripos International, St. Louis, MO 63144, USA.
40. Clark, M.; Cramer, R. D., III; van Opdenhosch, N. J. Comput. Chem. 1989, 10, 982.
41. Gasteiger, J.; Marsili, M. Tetrahedron Lett. 1978, 34, 3181.
42. Previously reported8 to be inactive due to compound decomposition during
handling